Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-09-28

Clinical Trial Update: Evaluation of Drug-drug Interaction Between LCZ696 and Sildenafil in Subjects With Mild to Moderate Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated potential drug-drug interaction between Entresto (sacubitril/valsartan) and sildenafil in adults with hypertension; results have been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Entresto (sacubitril/valsartan)
  • Viagra (Sildenafil)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Mild to Moderate Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2015-09-28